High Blood Press Cardiovasc Prev
December 2020
Introduction: Concerns have been raised about the possible harmfulness of angiotensin-converter enzyme inhibitors (ACEi) and aldosterone receptor blockers (ARB) in patients with COVID-19. However, few data from a European population have been published, especially from hypertensive patients.
Aim: To study the association between ACEi or ARB treatments and major adverse outcomes during hospitalisation in COVID-19 patients.